Teresa De Marco

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Pulmonary arterial hypertension and women
    Teresa De Marco
    Division of Cardiology, University of California, San Francisco, California 94143 0124, USA
    Cardiol Rev 14:312-8. 2006
  2. ncbi Evidence of diminished coronary flow in pulmonary hypertension: explaining angina pectoris in this patient group?
    Juha W Koskenvuo
    Division of Cardiology, Department of Medicine, University of California, San Francisco, USA
    Clin Physiol Funct Imaging 31:477-84. 2011
  3. ncbi Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients
    Nicolas Amabile
    Department of Medicine, Division of Cardiology, University of California at San Francisco, San Francisco, California, USA
    J Heart Lung Transplant 28:1081-6. 2009
  4. ncbi Treatment of pulmonary arterial hypertension with circulating angiogenic cells
    Rachel Mirsky
    Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    Am J Physiol Lung Cell Mol Physiol 301:L12-9. 2011
  5. ncbi Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study
    Teresa De Marco
    University of California, San Francisco Medical Center, San Francisco, CA, USA
    J Card Fail 14:9-18. 2008
  6. ncbi A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model
    Juha W Koskenvuo
    Division of Cardiology, Department of Medicine, University of California, 505 Parnassus Avenue, Box 0103, San Francisco, CA 94143, USA
    Int J Cardiovasc Imaging 26:509-18. 2010
  7. ncbi Association of African American race with elevated pulmonary artery diastolic pressure: data from the Heart and Soul Study
    Kiran K Khush
    Division of Cardiology, University of California, San Francisco, California 94143 0124, USA
    J Am Soc Echocardiogr 20:1307-13. 2007
  8. ncbi Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling
    Leslie A Saxon
    Cardiomyopathy and Arrhythmia Research and Education Center, University of California, San Francisco, Calif, USA
    Circulation 105:1304-10. 2002
  9. ncbi Role of nonglycosidic inotropic agents: indications, ethics, and limitations
    Kanu Chatterjee
    Department of Medicine, University of California at San Francisco, Chatterjee Center for Cardiac Research, Moffit Long Hospital, San Francisco, CA 94143, USA
    Med Clin North Am 87:391-418. 2003
  10. ncbi Arrhythmias associated with dilated cardiomyopathy
    Leslie A Saxon
    Cardiomyopathy and Arrhythmia Education Center (CARE, University of California, San Francisco, CA 94143-1354, USA
    Card Electrophysiol Rev 6:18-25. 2002

Collaborators

Detail Information

Publications33

  1. ncbi Pulmonary arterial hypertension and women
    Teresa De Marco
    Division of Cardiology, University of California, San Francisco, California 94143 0124, USA
    Cardiol Rev 14:312-8. 2006
    ..The clinical outcomes of patients with PAH have improved with the judicious use of contemporary therapies...
  2. ncbi Evidence of diminished coronary flow in pulmonary hypertension: explaining angina pectoris in this patient group?
    Juha W Koskenvuo
    Division of Cardiology, Department of Medicine, University of California, San Francisco, USA
    Clin Physiol Funct Imaging 31:477-84. 2011
    ..The role of pulmonary artery dilatation, septal wall motion abnormality, cardiac output or diastolic blood pressure in determining coronary blood flow (CBF) during PH was determined...
  3. ncbi Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients
    Nicolas Amabile
    Department of Medicine, Division of Cardiology, University of California at San Francisco, San Francisco, California, USA
    J Heart Lung Transplant 28:1081-6. 2009
    ..We hypothesized that the levels of circulating EMPs and LMPs could predict outcome in these patients...
  4. ncbi Treatment of pulmonary arterial hypertension with circulating angiogenic cells
    Rachel Mirsky
    Department of Medicine, University of California, San Francisco, San Francisco, California 94143, USA
    Am J Physiol Lung Cell Mol Physiol 301:L12-9. 2011
    ..Future studies should be geared toward either earlier therapeutic time points with varying doses of unmodified CACs or genetically modified cells as a means of delivery of factors to the pulmonary arterial circulation...
  5. ncbi Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study
    Teresa De Marco
    University of California, San Francisco Medical Center, San Francisco, CA, USA
    J Card Fail 14:9-18. 2008
    ....
  6. ncbi A comparison of echocardiography to invasive measurement in the evaluation of pulmonary arterial hypertension in a rat model
    Juha W Koskenvuo
    Division of Cardiology, Department of Medicine, University of California, 505 Parnassus Avenue, Box 0103, San Francisco, CA 94143, USA
    Int J Cardiovasc Imaging 26:509-18. 2010
    ..These non-invasive parameters may be used to replace invasive measurements in detecting successful disease induction and to complement invasive data in the evaluation of PAH severity in a rat model...
  7. ncbi Association of African American race with elevated pulmonary artery diastolic pressure: data from the Heart and Soul Study
    Kiran K Khush
    Division of Cardiology, University of California, San Francisco, California 94143 0124, USA
    J Am Soc Echocardiogr 20:1307-13. 2007
    ..We hypothesized that African American race is associated with an elevated EDPR gradient that may partially predispose African Americans to heart failure...
  8. ncbi Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling
    Leslie A Saxon
    Cardiomyopathy and Arrhythmia Research and Education Center, University of California, San Francisco, Calif, USA
    Circulation 105:1304-10. 2002
    ..Long-term ventricular resynchronization therapy improves symptom status. Changes in left ventricular remodeling have not been adequately evaluated...
  9. ncbi Role of nonglycosidic inotropic agents: indications, ethics, and limitations
    Kanu Chatterjee
    Department of Medicine, University of California at San Francisco, Chatterjee Center for Cardiac Research, Moffit Long Hospital, San Francisco, CA 94143, USA
    Med Clin North Am 87:391-418. 2003
    ..Thus, indications for the use of presently available nonglycosidic inotropic agents are limited and should be considered only for short-term therapy or when no other treatment is available...
  10. ncbi Arrhythmias associated with dilated cardiomyopathy
    Leslie A Saxon
    Cardiomyopathy and Arrhythmia Education Center (CARE, University of California, San Francisco, CA 94143-1354, USA
    Card Electrophysiol Rev 6:18-25. 2002
  11. ncbi Usefulness of the third heart sound in predicting an elevated level of B-type natriuretic peptide
    Gregory M Marcus
    Department of Cardiology, University of California San Francisco, M1180D, 505 Parnassus Avenue, San Francisco, CA 94143 0124, USA
    Am J Cardiol 93:1312-3. 2004
    ..Mean BNP levels were significantly higher in those with a third heart sound. The presence of a third heart sound was 41% sensitive and 97% specific for elevated BNP levels...
  12. ncbi Pulmonary hypertension: hemodynamic diagnosis and management
    Kanu Chatterjee
    Chatterjee Center for Cardiac Research, University of California, San Francisco 94143, USA
    Arch Intern Med 162:1925-33. 2002
    ..The therapeutic approaches can be directed to the hemodynamic mechanisms of pulmonary hypertension...
  13. ncbi Transplantation in adults with congenital heart disease
    Dana McGlothlin
    Division of Cardiology, Heart Failure, Heart Transplantation, and Pulmonary Hypertension Programs, University of California, San Francisco, CA, USA
    Prog Cardiovasc Dis 53:312-23. 2011
    ..However, those who survive of the first posttransplant year enjoy an excellent long-term prognosis...
  14. ncbi Nesiritide acutely increases pulmonary and systemic levels of nitric oxide in patients with pulmonary hypertension
    Kiran K Khush
    Division of Cardiology, University of California at San Francisco Medical Center, San Francisco, California, USA
    J Card Fail 12:507-13. 2006
    ..020). CONCLUSION: In PH patients, nesiritide infusion significantly increases NOx levels, suggesting a novel mechanism for its vasodilatory effects. These responses may differ between pre- and postcapillary PH patients...
  15. ncbi Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
    Michael R Bristow
    Division of Cardiology, University of Colorado Health Sciences Center, Denver, CO 80262, USA
    N Engl J Med 350:2140-50. 2004
    ....
  16. ncbi Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy
    Gregory M Marcus
    Department of Medicine, Division of Cardiology, University of California, San Francisco, San Francisco, California, USA
    J Am Coll Cardiol 46:2208-14. 2005
    ..CONCLUSIONS: The previous findings that SPWMD predicts reverse remodeling or clinical improvement with CRT were not reproducible in patients randomized in the CONTAK-CD trial...
  17. ncbi Effects of intravenous nesiritide on pulmonary vascular hemodynamics in pulmonary hypertension
    Andrew D Michaels
    Division of Cardiology, Department of Medicine, University of California at San Francisco Medical Center, 94143, USA
    J Card Fail 11:425-31. 2005
    ..The lack of acute beneficial effects of nesiritide in patients with advanced precapillary PH may be related to their relatively fixed remodeling of the pulmonary vasculature...
  18. ncbi Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices
    Tamara Horwich
    Division of Cardiology, UCLA School of Medicine, Los Angeles, California, USA
    J Cardiovasc Electrophysiol 15:1284-9. 2004
    ..CONCLUSION: "Upgrading" RV paced patients with advanced heart failure to CRT improves measures of electrical and LV mechanical synchrony and improves systolic function...
  19. ncbi Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension
    Hubert Chen
    Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, CA 94143 0924, USA
    Am J Respir Crit Care Med 180:468-74. 2009
    ..In 2005, lung allocation for transplantation in the United States changed from a system based on waiting time to a system based on the Lung Allocation Score (LAS)...
  20. ncbi Isolated bundle branch block and left ventricular dysfunction
    Seung-Joon Lee
    University of California, San Francisco, USA
    J Card Fail 9:87-92. 2003
    ..9 +/- 4% in isolated right BBB cohort and -1.1 +/- 3% reduction in the isolated nonspecific intraventricular conduction delay cohort (P =.019). CONCLUSIONS: Left bundle branch block itself may be a cause of ventricular dysfunction...
  21. ncbi Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database
    Clyde W Yancy
    Division of Cardiology, Department of Medicine, University of Texas Southwest Medical Center, Dallas, Texas 75390 9047, USA
    J Am Coll Cardiol 47:76-84. 2006
    ..Medical treatment strategies for patients with preserved systolic function are inconsistent and reflect the need for efficacious evidence-based treatment regimens...
  22. ncbi Secondhand smoke exposure and quality of life in patients with heart failure
    Sarah G Weeks
    Division of Cardiology, University of California School of Medicine, 505 Parnassus Ave, PO Box 0124, San Francisco, CA 94030
    Arch Intern Med 171:1887-93. 2011
    ..Secondhand smoke (SHS) exposure is associated with an increased risk of atherosclerotic heart disease and cardiac events. We sought to assess the effect of SHS on health-related quality of life (HRQOL) in patients with heart failure...
  23. ncbi Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension
    Nicolas Amabile
    Division of Cardiology, Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 0103, USA
    Am J Respir Crit Care Med 177:1268-75. 2008
    ..Endothelial MPs are a biological marker of dysfunctional endothelium. Vascular remodeling and endothelial dysfunction are involved in pulmonary hypertension (PH)...
  24. ncbi Long-term follow-up of portopulmonary hypertension: effect of treatment with epoprostenol
    Oren K Fix
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Liver Transpl 13:875-85. 2007
    ..Liver biochemistries are not greatly changed. Survival seemed not to differ between treatment groups. A minority of patients treated with epoprostenol will improve sufficiently to undergo OLT...
  25. ncbi Adjudication of mortality events in a heart failure-arrhythmia trial by a multiparameter descriptive method: comparison with methods used in heart failure trials and methods used in arrhythmia trials
    John P Boehmer
    Division of Cardiology, The Milton S Hershey Medical Center, The Pennsylvania State College of Medicine, Rm 1512, 500 University Drive, Hershey, PA, 17033, USA
    J Interv Card Electrophysiol 23:101-10. 2008
    ..quot; Herein, we describe an adaptation of this descriptive method in a trial of patients with heart failure and arrhythmias...
  26. ncbi The MIRACLE trial has merit
    Teresa De Marco
    Division of Cardiology, Department of Medicine, University of California, San Francisco 94143-0124, USA
    J Card Fail 8:204-5. 2002
  27. ncbi {alpha}1-Adrenergic receptor subtypes in nonfailing and failing human myocardium
    Brian C Jensen
    Cardiology Section and Research Service, San Francisco VA Medical Center, San Francisco, Calif, USA
    Circ Heart Fail 2:654-63. 2009
    ..Here, we test the hypothesis that the alpha1A and alpha1B subtypes are present in human myocardium, similar to the mouse, and are not downregulated in heart failure...
  28. ncbi Cost effectiveness of cardiac resynchronization therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) trial
    Arthur M Feldman
    Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA
    J Am Coll Cardiol 46:2311-21. 2005
    ....
  29. ncbi Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias
    Steven L Higgins
    Scripps Memorial Hospital, La Jolla, California 92038 0028, USA
    J Am Coll Cardiol 42:1454-9. 2003
    ..This study was conducted to assess the safety and effectiveness of cardiac resynchronization therapy (CRT) when combined with an implantable cardioverter defibrillator (ICD)...
  30. ncbi Cardiac troponin and outcome in acute heart failure
    W Frank Peacock
    Department of Emergency Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    N Engl J Med 358:2117-26. 2008
    ..The purpose of our study was to describe the association between elevated cardiac troponin levels and adverse events in hospitalized patients with acute decompensated heart failure...
  31. ncbi Utility of CT for predicting pulmonary hypertension in patients with parenchymal lung disease: similar results, different conclusion?
    Hubert Chen
    Chest 133:1053-4; author reply 1054. 2008
  32. ncbi Kaposi sarcoma-associated herpesvirus and primary and secondary pulmonary hypertension
    A Scott Laney
    University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA
    Chest 127:762-7. 2005
    ..CONCLUSION: Our data do not support KSHV infection having a significant role in PPH or non-HIV-associated secondary PH compared to age- and gender-matched control subjects...
  33. ncbi Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial
    Leslie A Saxon
    Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Circulation 114:2766-72. 2006
    ..The factors that determine the risk for sudden death or implantable cardioverter defibrillator therapy in patients receiving cardiac resynchronization therapy (CRT) therapies are largely unknown...